CD40L-expressing, CD28ζ-signaling CAR T cells show enhanced CAR T-cell activation and improved the antigen-presenting cell (APC) phenotype of CLL cells (57). Here, CD40LG is linked to B-cell chronic lymphocytic leukemia.